North American Relocation & Business Investments

1140 Burnhamthorpe Rd W #141,
Mississauga, Ontario, L5C 2S9, Canada
Tel: +1-647-499-4905
Fax: 1.888.406.0201
Email: info@north-american.org


Contact Form:






Extra Testosterone Will Not Boost Physical

Extra Testosterone Will Not Boost Physical

The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved nearly 800 older men with low testosterone and symptoms associated with this condition, like http://tinyurl.com/zwvtvex sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.



testosterone therapy side effects depressionThe recent conflicting findings on testosterone treatment prompted his team to conduct a big systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in America suffer from low testosterone, which occurs when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This describes the sudden weight gain, obvious aging and decline of energy of a person.

And many women have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes this will likely stay the status quo for a while, given the prohibitive cost of conducting the long-term safety studies needed to win fuller FDA acceptance.